Biovie submitted trial data to the U.S. Food and Drug Administration and announced results from its offices in Carson City, Nev.
2 reports, 2 independent
Updated Aug 6
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Biovie submitted trial data to the U.S. Food and Drug Administration and announced results from its offices in Carson City, Nev.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Biovie
French company founded in 2007, specializing in online sales of organic, raw, and living foods, committed to education on healthy eating.
Nothing else this week.
- FDA
-
Nasdaq
American fully electronic stock exchange
Related events
- Abivax SA, a French company, is conducting clinical trials in the US and seeking alignment on NDA submission strategy with the FDA.
- Tarsus Pharmaceuticals is seeking FDA approval in the US and is listed on the Nasdaq stock exchange.
- FDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.
- Company Q783794 was listed on the Nasdaq stock exchange.
- Mentari Therapeutics, Inc. was listed on the Nasdaq stock exchange on November 4, 2026.